TKUN Stock Chart & Stats
311.00
0.00(0.00%)
At close: 4:00 PM EDT
311.00
0.00(0.00%)
Day’s Range― - ―
52-Week Range170.00 - 4,000.00
Previous CloseN/A
Volume30.00
Average Volume (3M)38.91K
Market Cap
₪1.84M
Enterprise Value23.81M
Total Cash (Recent Filing)₪287.00K
Total Debt (Recent Filing)₪11.79M
Price to Earnings (P/E)―
Beta0.27
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-18.68
Shares Outstanding849,645
10 Day Avg. Volume53,526
30 Day Avg. Volume38,907
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-1.53
Price to Sales (P/S)2.21
P/FCF Ratio32.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TKUN FAQ
What was Tikun Olam-Cannbit Pharmaceuticals Ltd.’s price range in the past 12 months?
Tikun Olam-Cannbit Pharmaceuticals Ltd. lowest stock price was 170.00 and its highest was 4000.00 in the past 12 months.
What is Tikun Olam-Cannbit Pharmaceuticals Ltd.’s market cap?
Tikun Olam-Cannbit Pharmaceuticals Ltd.’s market cap is ₪1.84M.
When is Tikun Olam-Cannbit Pharmaceuticals Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Tikun Olam-Cannbit Pharmaceuticals Ltd.’s earnings last quarter?
Tikun Olam-Cannbit Pharmaceuticals Ltd. released its earnings results on Aug 24, 2021. The company reported -33.3 earnings per share for the quarter, missing the consensus estimate of N/A by -33.3.
Is Tikun Olam-Cannbit Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Tikun Olam-Cannbit Pharmaceuticals Ltd.’s price is currently Overvalued.
Does Tikun Olam-Cannbit Pharmaceuticals Ltd. pay dividends?
Tikun Olam-Cannbit Pharmaceuticals Ltd. pays a Monthly dividend of 1411346.9 which represents an annual dividend yield of N/A. See more information on Tikun Olam-Cannbit Pharmaceuticals Ltd. dividends here
What is Tikun Olam-Cannbit Pharmaceuticals Ltd.’s EPS estimate?
Tikun Olam-Cannbit Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tikun Olam-Cannbit Pharmaceuticals Ltd. have?
Tikun Olam-Cannbit Pharmaceuticals Ltd. has 849,645 shares outstanding.
What happened to Tikun Olam-Cannbit Pharmaceuticals Ltd.’s price movement after its last earnings report?
Tikun Olam-Cannbit Pharmaceuticals Ltd. reported an EPS of -33.3 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Tikun Olam-Cannbit Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IL:TKUN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tikun Olam-Cannbit Pharmaceuticals Ltd.
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers clinical research, training, and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd was founded in 2006 and is based in Nof HaGalil, Israel.